New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures,...

FDA Drug Recall #D-0270-2023 — Class II — February 9, 2023

Recall Summary

Recall Number D-0270-2023
Classification Class II — Moderate risk
Date Initiated February 9, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm HTO Nevada, Inc.
Location Lake Oswego, OR
Product Type Drugs
Quantity 4709 bottles

Product Description

New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain sensitive procedures, 1 oz bottle, distributed by Dermal Source, Portland, OR, www.dermalsource.com 1-888-568-3223. NDC Code: 80069-008-01. Drug Facts- For use by licensed professionals only, Active Ingredients -Lidocaine HCL (5%), Tetracaine HCL (1%) and epinephrine (0.1%).

Reason for Recall

cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.

Distribution Pattern

Nationwide in the USA and Canada.

Lot / Code Information

Lot #s: 796CP-0006, Exp 02/2024; 796CP-0007, Exp 03/2024.

Other Recalls from HTO Nevada, Inc.

Recall # Classification Product Date
D-0271-2023 Class II Maximum Zone2 Topical Analgesic, 1oz bottle, fo... Feb 9, 2023

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.